Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CODIP

Financiado

Cerrado

Cortical Disorganization in Psychosis. Neurophysiological clinical and genetic...

Cortical Disorganization in Psychosis. Neurophysiological clinical and genetic factors "Background: Schizophrenia and bipolar disorder are severe mental illnesses which cause high rates of disability, social and economic costs. Although there is compelling evidence of a genetic contribution to psychosis and we know... ver más

05/05/2015

UNIVERSITY COLLEGE...

222K€

Presupuesto del proyecto: 222K€

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-05-05 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITY COLLEGE LONDON

221.61K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PRISM 2 Psychiatric Ratings using Intermediate Stratified Markers 2 8M€ Cerrado

TRIP Translational Research into Psychiatric disorders genetics... 714K€ Cerrado

ToPP Towards Precision Psychiatry 202K€ Cerrado

COSYN Comorbidity and Synapse Biology in Clinically Overlapping Ps... 6M€ Cerrado

PRISM Psychiatric Ratings using Intermediate Stratified Markers... 16M€ Cerrado

PID2021-122853OA-I00 NEUROIMAGEN GENETICA PARA LA CARACTERIZACION DE TRAYECTORIAS... 254K€ Cerrado

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 222K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Background: Schizophrenia and bipolar disorder are severe mental illnesses which cause high rates of disability, social and economic costs. Although there is compelling evidence of a genetic contribution to psychosis and we know deficits in neuronal connectivity are a key factor, the pathophysiology and aetiology of the disease remain poorly understood. Aims: (i) To identify biomarkers of neural dys-connectivity characterising psychosis through neurophysiological and neuropsychological techniques. (ii) To apply such biomarkers in genetic association studies in order to understand the mechanisms by which variation at certain loci leads to the onset of the disease. Methods: Neurophysiology is a non-invasive and inexpensive technique with a superb temporal resolution that allows the study of perceptual and cognitive processes in vivo. My UCL supervisor and I have collected a large sample of families with psychosis cases including 300 patients, 220 unaffected relatives and 300 controls. Participants completed a battery of experiments including resting EEG, P300 wave, P50 gating, Mismatch Negativity and cognitive assessments. I will train in advanced analytics using Dynamic Causal Modeling (DCM), which tests models of neural activity and its synchronisation deficits and is a new tool in psychiatry. Through DCM I will identify novel measures of brain dys-connectivity to use as phenotypes for genetic association. I will examine candidate genes, identified through association studies using Plink and Unphased software. I will train in gene ontology tools to perform pathway analyses using the extensive genome-wide genotyping that is already available on my sample. UCL, a centre of excellence in neuroscience, will host my research. Implications: Biomarkers of brain connectivity could be used towards the earlier detection and treatment of psychosis. Understanding the mechanisms of action of susceptibility genes is essential to develop safer and more effective new treatments."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores